Serving Pediatric Patients

How do we serve pediatric patients with rare immune diseases? Manish Butte, MD, PhD, a pediatric immunologist at UCLA Health talks about bringing advanced laboratory capabilities to kids with rare immune diseases
Learn More →

UCLA’s Expertise In Immunology Ranges Far And Wide

Innovation at UCLA extends far beyond a moment of discovery. 

UCLA faculty have developed best-in-class T-cell therapies for fighting and beating cancer and for world-leading transplant programs. They have uncovered and invented new ways to prevent and treat infection to meet the challenge of antibiotic resistance.

Their groundbreaking discoveries have unlocked the genetics and cell biology of immunity. Now, they are building mathematical models of human health. Here—now—we are harnessing the power of the immune system to prevent, treat, and cure disease.

Dr. Lili Yang

Dr. Lili Yang

Engineered killer T cells could provide long-lasting immunity against cancer. UCLA researchers use stem cells to engineer cells that attack human tumors in mice.

Read about killer T cells
Connie Frank and Evan Thompson

A Generous Contribution

To establish the Connie Frank and Evan Thompson Program for Restorative Transplantation Research, under the direction of Dr. Kodi Azari (FEL ’04) in the Department of Surgery.

See donor spotlight

Once we fully understand the rules of the immune system, then we can harness the immune system therapeutically to cure disease.

Gay M. Crooks, MD, Director, I3T Research Theme

I3T Seminar Series

The I3T Seminar Series 2023-24 is back in person this year with an outstanding lineup of speakers. We have already confirmed dates with the speakers below. All our seminars start at 12pm and conclude at 1pm. Contact us at I3T@mednet.ucla.edu for any questions. 

View Seminar Series

 

Upcoming Seminars

u medium

Speakers: Alex Yoo (Crooks Lab) & Zhenlan Yao (Li Lab) 
Institution: UCLA 
Date: Tuesday, May 21, 2024
Location: In-person CHS 23-105
Additional Information: Research In Progress

Talk Titles: "Engineering Developmental Cues to Generate iPSC-derived, TCR-null CAR T cells for Immunotherapy" & "Evolutionary arms race between chikungunya virus glycoprotein and host factors drive efficient virion production in macrophages."

 

 

 

Janet Markle

Speaker: Janet Markle, PhD
Title: Assistant Professor of Pathology, Microbiology, & Immunology
Institution: Vanderbilt University
Date: Tuesday, June 11, 2024
Location: In-person CHS 23-105

Talk Title: "Learning about mechanisms of immunity and inflammation through the study of patients with rare monogenic diseases"